- Product Usage: THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
Retatrutide is a synthetic multi-agonist peptide designed to interact with GLP-1, GIP, and glucagon receptors in research settings. In preclinical and early translational research, it has been studied for its role in metabolic regulation, energy expenditure signaling, and body-composition–related pathways, making it a compound of interest in metabolic and endocrine research models.
$109.97
- Products will arrive in a lyophilized (powder) form for maximum stability
Retatrutide is a synthetic multi-agonist peptide designed to interact with GLP-1, GIP, and glucagon receptors in research settings. In preclinical and early translational research, it has been studied for its role in metabolic regulation, energy expenditure signaling, and body-composition–related pathways, making it a compound of interest in metabolic and endocrine research models.
$109.97
- Products will arrive in a lyophilized (powder) form for maximum stability
-
Description
-
Additional information
-
Reviews (0)
Retatrutide is a synthetic multi-agonist peptide designed to interact with GLP-1, GIP, and glucagon receptors in research settings. In preclinical and early translational research, it has been studied for its role in metabolic regulation, energy expenditure signaling, and body-composition–related pathways, making it a compound of interest in metabolic and endocrine research models.
Research Focus
Retatrutide is commonly explored in laboratory research involving:
- Metabolic homeostasis and energy balance signaling
- GLP-1, GIP, and glucagon receptor pathway studies
- Lipid metabolism and adipose tissue research
- Appetite and nutrient-partitioning signaling models
- Obesity and metabolic dysfunction research
Research-Observed Effects
Preclinical studies suggest Retatrutide may support:
- Modulation of metabolic and energy-regulation pathways
- Enhanced lipid utilization and energy expenditure signaling
- Integrated multi-pathway metabolic response models
Findings are based on laboratory and experimental research only.
Product Specifications
- Peptide:
Retatrutide - Type:
Synthetic multi-agonist peptide - Molecular Weight:
~4,100 g/mol (approx.) - CAS Number:
2381089-83-2 - Purity:
≥99% (HPLC Verified) - Form:
Lyophilized powder
Quality & Compliance
- HPLC & MS verified
- Manufactured under controlled conditions
- For Research Use Only (RUO)
- Not for human or veterinary use
⚠️ This product is intended strictly for research purposes only and is not approved for human or veterinary use.
| Weight | 100 mg |
|---|
Reviews
There are no reviews yet.